Publication Name	World Journal of Gastroenterology
Manuscript ID	14027
Country	South Korea

Received	2014-09-15 08:44
Peer-Review Started	2014-09-15 21:06
To Make the First Decision	2014-10-14 16:55
Return for Revision	2014-10-17 08:20
Revised	2014-10-18 11:13
Second Decision	2014-11-11 10:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-11 10:55
Articles in Press	2014-11-11 11:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-02-08 20:52
Publish the Manuscript Online	2015-02-28 17:07

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy
Manuscript Source	Unsolicited Manuscript
All Author List	Jung Gil Park, Soo Young Park and Hye Won Lee
Funding Agency and Grant Number
Corresponding Author	Soo Young Park, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, South Korea. psyoung0419@gmail.com
Key Words	Hepatocellular carcinoma; Radiofrequency ablation; Sorafenib; Down-staging; Complete remission
Core Tip	Though sorafenib is well known to efficacy in advanced hepatocellular carcinoma (HCC), the consensus of its role as down-staging is limited. Depending on response after sorafenib therapy, active strategy should be needed to offer chance for cure in advanced stage HCC.
Publish Date	2015-02-28 17:07
Citation	Park JG, Park SY, Lee HW. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy. World J Gastroenterol 2015; 21(8): 2568-2572
URL	http://www.wjgnet.com/1007-9327/full/v21/i8/2568.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i8.2568

Full Article (PDF)	WJG-21-2568.pdf
Full Article (Word)	WJG-21-2568.doc
Manuscript File	14027-Review.docx
Answering Reviewers	14027-Answering reviewers.pdf
Copyright License Agreement	14027-Copyright assignment.pdf
Peer-review Report	14027-Peer review(s).pdf
Scientific Misconduct Check	14027-CorssCheck.jpg
Scientific Editor Work List	14027-Scientific editor work list.pdf